Schedule 13D ownership disclosure
MARINUS PHARMACEUTICALS INC
Security class unavailable · CUSIP: 56854Q200
Event date: Unavailable
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 619,221
- Percent of class
- 2.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000904454-20-000638
- Form type
- SC 13D
- Filer
- Domain Partners VI, L.P.
- CIK
- CIK 1298033
- Filed
- Sep 29, 2020
- Reporting period
- —
- Description
- Schedule 13D beneficial ownership